Latest Posts › Infectious Diseases

Share:

COVID-19 Weekly Newsletter: Biden Announces Ambitious Vaccination Plan

With Inauguration Day rapidly approaching, President-elect Biden has announced an ambitious vaccination plan, and the federal government has signaled a change to its vaccine distribution process, among other COVID-19...more

COVID-19 Weekly Newsletter: U.S. Suffers Deadliest Days for COVID-19

In an otherwise troubling week, there are some positive developments in the COVID-19 response, including progress in the development of a new vaccine. The Pandemic Is Far from Over: 4000 Lives Gone in One Day ...more

COVID-19 Weekly Newsletter: FDA Committee Recommends Vaccine Approval

A milestone in the vaccine approval process and a bipartisan relief package proposal highlighted a busy week in the COVID-19 response. COVID-19 Relief Package - This week, a group of bipartisan senators put forth the...more

COVID-19 Weekly Newsletter: Vaccine Progress Report

As countries in the Western Hemisphere prepare for the first shipments of vaccines, researchers continue to release new COVID-19 findings. Vaccine News Galore! U.K. Approves COVID-19 Vaccine, Ahead in the Western World:...more

COVID-19 Weekly Newsletter: Positive Developments in the Race for a COVID-19 Vaccine

Positive news is emerging on the vaccine front in the fight against COVID-19, as one vaccine candidate is reported to have prevented more than 90% of symptomatic infections in clinical trials, and another was granted a Fast...more

COVID-19 Weekly Newsletter: New Cases Climb in the U.S.

The daily number of new positive COVID-19 cases in the U.S. has exceeded 100,000 twice in the past week, prompting some states to issue more restrictive safety measures and guidance. Amid these heightened concerns, the most...more

COVID-19 Weekly Newsletter: 8+ Million Cases in the U.S. and Counting

Amid spikes on in the U.S, and Europe, Congress continues to ponder a relief bill, the White House released a plan to cover COVID-19 vaccine costs, and new data showed that chronic exposure to low-quality air increased...more

COVID-19 Weekly Newsletter: U.S. Eyes Third Wave as Scientific Understanding, FDA Actions Advance

As talks of a third wave of infections bubble up and political negotiations over another COVID-19 relief package continue to stall, the pressure is on for the health and life science fields to better understand and tamp down...more

COVID-19 Weekly Newsletter: Second Wave Hits Europe, Reinfection Cases Emerge

As a second COVID-19 wave hits Europe, many countries are implementing lockdown restrictions to flatten the curve. The second wave coincides with a pause in two vaccine clinical trials and the emergence of some documented...more

COVID-19 Weekly Newsletter: Vaccine Development Progresses as Cases Spike in the U.S.

There are an average of 45,000 new COVID-19 cases in the United States daily, an increase of 8% from the previous week. States that were already on an upward trajectory are getting worse and hospitalizations are on the rise,...more

COVID-19 Weekly Newsletter: Case Count, Death Toll Both Rising as Public Health Officials Work to Instill Confidence in a Vaccine

As COVID-19 cases rise across the U.S. and the death toll tops a staggering 200,000, four public health officials expressed confidence in an eventual vaccine even as the public's confidence in the vaccine appears to be waning...more

COVID-19 Weekly Newsletter: Researchers Study Dining Risks, Asymptomatic Transmission

A recent report from the Centers for Disease Control and Prevention (CDC) revealed that dining out carries heightened risk of COVID-19 transmission, but did not reveal a similar heightened risk related to travel. Studies...more

COVID-19 Weekly Newsletter: Pharma Companies Sign Vaccine Pledge, Relief Package Stalls

AstraZeneca’s Phase 3 vaccine clinical trials came to a halt this week as the pharmaceutical company works to identify the underlying cause of a case of transverse myelitis emerging in a volunteer. The pause coincided with...more

63 Results
 / 
View per page
Page: of 3

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide